26 May 2017 / News & Events

ICH-Good Clinical Practice (GCP) Training Course” recognised by TransCelerate BioPharma Inc.

The e-learning “ICH-Good Clinical Practice (GCP) Training Course”, organised by Consorzio per Valutazioni Biologiche e Farmacologiche in the framework of Work Package 4, meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified as necessary to enable mutual recognition of GCP training among trial sponsors as recognised by TransCelerate BioPharma.

TransCelerate BioPharma Inc. is a non-profit organization dedicated to improving the health of people around the world by accelerating and simplifying the research and development (R&D) of innovative new therapies. Consorzio per Valutazioni Biologiche is recognised as an accredited training provider at international level with the GAPP “ICH-Good Clinical Practice (GCP) Training Course”.

Donato Bonifazi, Chief Executive Officer at CVBF commented at this recognition: “We are pleased that the TransCelerate member companies recognise that our ICH-GCP training course reflects their best practices for training. The course is based on the international E6 ICH Good Clinical Practice (R2) and is aimed at providing a guide for all individuals that are involved in clinical research and clinical trials and they need to acquire GCP knowledge. In this way, the participant will be aware of his/her role and responsibilities and will understand how GCP can be applied practically in the research setting“.

Share this article on:share on twittershare on facebookshare on linked in

Please subscribe to the GAPP Project newsletter to receive our latest updates.